-+ 0.00%
-+ 0.00%
-+ 0.00%

*Bristol Myers Squibb: In Legacy Portfolio, Revenue Growth Was Primarily Driven by Eliquis in 3Q, Partially Offset by Expected Continued Generic Impacts Across Remainder of Portfolio >BMY

Dow Jones·10/29/2026 11:00:17

Veuillez vous connecter pour afficher les détails des actualités